The Stack Raises ₹21.5 Crore to Scale Trusted Supplements Brand
The supplements startup will invest in research, hiring and product expansion after reporting fivefold growth in six months.

The Stack, an Indian supplements brand focused on clinically studied ingredients and transparent formulations, has raised ₹21.5 crore in a funding round co-led by Sauce, OTP Ventures and Huddle Ventures.
The company plans to use the capital to expand its team, strengthen research and development, and broaden its product portfolio. The round follows The Stack’s first institutional raise of ₹5.5 crore in January 2026. The brand says it has grown fivefold in six months and is targeting six-to-seven-times growth in FY 2026–27 compared with the previous financial year.
The Stack currently sells five products, reflecting a deliberate focus on a limited range rather than a broad catalogue. According to the company, one in three customers places a repeat order within six months, while many customers pay upfront for six-to-twelve-month subscriptions. The top 10% of customers account for 30% of revenue, and referrals and word of mouth contribute strongly to new customer acquisition.
Co-founder Kshitij Rihal said the company has focused on avoiding unnecessary launches and trending ingredients that do not meet its standards. He added that the goal is to build a smaller range of products customers repeatedly use rather than a large catalogue that encourages one-time trials.
Investors said The Stack’s emphasis on minimal ingredients, formulation quality, efficacy and transparency helped distinguish it in India’s fast-growing supplements market. Participants in the round included Samina Hamied, founder and managing partner at AYRA Ventures.
The funding comes as Indian consumers increasingly seek clean-label products, traceable sourcing and clearer information about ingredients and dosage. The Stack aims to become India’s most trusted supplements brand over the next three years by combining focused use cases with globally sourced raw materials and evidence-led formulations.
Co-founder Shreya said the company wants customers to associate every launch with careful work on ingredients, dosage and sourcing, without unnecessary upselling.
Discover more from Global Business Line
Subscribe to get the latest posts sent to your email.




